Exchange: NYSE·Updated 02:12 PM EDT

CLB News

News
all
press releases
CLB Declines 35% in the Past Six Months: How to Play the Stock?
Core Laboratories' 35.1% six-month slide contrasts with stronger Production Enhancement trends and offshore recovery potential amid geopolitical risks.
Zacks
CLB Declines 35% in the Past Six Months: How to Play the Stock?
Core Laboratories' 35.1% six-month slide contrasts with stronger Production Enhancement trends and offshore recovery potential amid geopolitical risks.
Zacks
More News
LBRT Stock Soars 79% in a Year: Should Investors Wait or Move On?
Liberty Energy's 79% surge in a year reflects power expansion and tech strength. However, weaker profits, rising debt and execution risks warrant caution.
Zacks
Zacks Industry Outlook Highlights TechnipFMC, Oceaneering International, Inc. and Core Laboratories
Oilfield services face spending and debt challenges, but TechnipFMC, Oceaneering and Core Laboratories show resilience and growth potential.
Zacks
3 Oilfield Services Stocks Poised to Gain Despite Industry Challenges
Strict capital discipline by upstream energy companies is acting as a dampener, making the outlook for the Zacks Oil and Gas-Field Services industry gloomy. FTI, OII and CLB are expected to survive the industry woes.
Zacks
Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
DTI or CLB: Which Is the Better Value Stock Right Now?
DTI vs. CLB: Which Stock Is the Better Value Option?
Zacks
Williams Companies Q2 Earnings & Revenues Miss Estimates, Increase Y/Y
WMB's Q2 earnings and revenues miss estimates but rise year over year as it raises 2026 EBITDA guidance and expands its gas network.
Zacks
Diamondback Energy Q2 Earnings Beat Estimates, Revenues Rise Y/Y
FANG tops Q2 earnings and revenue estimates as higher realized oil prices, production growth and a boosted buyback plan underscore a strong quarter.
Zacks
Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?
Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geopolitical pressure keep the near-term case cautious.
Zacks
Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y
CLB's Q2 earnings top estimates despite lower revenues and profit as Production Enhancement strength offsets Reservoir Description weakness.
Zacks

Advertisement|Remove ads.